Abbreviations used: AlB, a-Aminoisobutyric acid; BBB, blood-brain barrier; DTPA, diethylenetriaminepentaacetic acid; ECF, extracellular fluid; ECS, extracellular space; MeAIB, N-methyl-a-aminoisobutyric acid. 215 brain cells) were inserted into the model and apparent blood-to-brain transfer constants (K J were obtained. In addition, the two basic sets of transfer numbers were al tered to mimic various experimental and pathological changes in blood -brain transport. The results of this analysis indicate that moderate to large transfer rates across the BBB (0.01-1.0 ml g�1 min�l) are more easily and reliably measured by AlB-like compounds, In con trast, compounds like DTPA are better test-molecules for measuring small changes in the BBB transfer rate (0.0001-0.001 ml g�1 min�I), provided an appropriate ex perimental time is chosen. Key Words: a-Aminoisobu tyric acid-Blood-brain barrier-Blood -brain trans port-Diethylenetriaminepentaacetic acid-Theoretical analysis.
Summary: Reliable blood-brain transfer constants can be determined from data obtained in single-time experi ments (i.e., a single experimental time for tissue sam pling). The accuracy of such measurements depends on factors such as the test molecule used and the experi mental time chosen; therefore, the selection of optimal ex perimental conditions is important. In this presentation, a model of transport across the blood -brain barrier (BBB) was developed and used to determine appropriate ex perimental protocols for single-time experiments. Trans fer numbers derived from published data with a aminoisobutyric acid (AlB; a compound of low BBB permeability that is readily taken up by brain cells) and diethylenetriaminepentaacetic acid (DTPA; a compound of very low BBB permeability that is not taken up by
We have argued that the most accurate and reli able way of measuring unidirectional blood-to-brain transfer constants employs graphical analysis of the tissue-uptake data obtained from a number of mea surements or experiments of differing duration (multiple-time/graphical analysis) (Fenstermacher et aI., 198 1; Blasberg et aI., 1983; Patlak et aI., 1983) . The advantages of the multiple-time/ graphical approach include the ready assessment of the unidirectional uptake phase, the ease and ac curacy with which the tissue data are corrected for the amount of the test substance that has not com pletely crossed the blood-brain barrier (BBB), and the production of a relatively model-independent transfer constant.
There is, however, a number of experimental situations in which the mUltiple-time/graphical analysis method cannot be used. For instance, if the transport properties of the system are rapidly changing with respect to the range of desired ex perimental times or if the experimental model or pathological lesion is not similar among the animals in the series, then the mUltiple-time/graphical ap proach will yield spurious estimates and another technique must be used. In such cases, the employment of a single experimental time for tissue sampling and an assumption of negligible brain-to blood backflux, as done by Rapoport et al. (1980) , is in order, provided the appropriate experimental conditions have been met.
When using the single-time approach to deter mine blood-to-brain transfer constants, the inves tigator consciously or unconsciously chooses a number of experimental conditions that set the range of transfer constants that can be accurately determined and the validity of the experimental measurements. These conditions include the test compound, the administration schedule (and thus the time course of plasma concentrations), and the experimental duration. There are also several ex perimental conditions that the researcher cannot set or control but should consider in selecting the pro tocol. Among these are the capillary permeability and surface area, the tissue distribution volume of the test material, and the capillary blood flow.
In the present paper, a theoretical analysis is made of the single-time method for measuring blood-to-brain transfer constants under conditions of both normal and elevated BBB permeability. This analysis is based on an assumed model of blood -brain transport and two separate sets of transfer numbers [one set is based on the extracel lular marker diethylenetriaminepentaacetic acid (DTPA), and the other set on the small neutral amino acid marker a-aminoisobutyric acid (AlB); Blasberg et aI., 1983] , which yields the amounts of DTPA and AlB in the various parts of the system as a function of time. From these tissue and plasma distribution values, apparent blood-to-brain transfer constants (K J are calculated [assuming the same transport model and operational equation as Go and Pratt (1975) , Ohno et al. (1978) , Gjedde and Ras mussen (1980) , and Rapoport et al. (1980) ] and compared to the actual model values. In addition to this analysis for the two basic sets of transfer num bers, further analyses were made for different cases with "higher BBB permeability." The results of this theoretical exercise have pedagogical value and provide the investigator with an appreciation of the best protocol design when making single-time tissue measurements and calculating apparent blood-to brain transfer constants under various experimental conditions.
MODELING BLOOD-BRAIN TRANSFER
A transport model for the blood -brain transfer of solutes is presented in Fig. 1 . This is a four compartment model in which the BBB is considered to be a single membrane between plasma and the extracellular fluid (ECF), and contains a reversible compartment, indicated by the subscript "r," in parallel with the BBB and brain ECF. In this model, Vr exchanges only with the plasma; no exchange occurs between Vr and either Ve or Vc' The units of V are volume per unit mass of brain tissue and the specific tissue compartment is indicated by the sub script ("p," "e," "c," and "r" represent plasma, ECF, parenchymal cells, and the reversible region, respectively .:: 1-
FIG. 1. Four-compartment unit-membrane model of solute exchange between-denoted by the subscripts in parentheses-blood or plasma (p), brain ECF (e), brain cells (c), and a parallel compartment that exchanges only with blood or plasma (r). C represents concentration (amount per unit volume of fluid) and A represents an amount (amount per unit mass of tissue).
been included in the brain sample (Blasberg et aI., 1983) . Before proceeding further with the description of this model, an explanation is in order. We do not claim that this model is the correct representation of the blood-brain transport system but only that it is consistent with the published experimental data (Blasberg et aI., 1983) . That is, the observations made with the parallel model are qualitatively true even if the actual BBB system is somewhat different from the model illustrated in Fig. 1 and used in this theoretical analysis.
The differential equations for the transport model represented in Fig. 1 
where Eqs. 1 and 2 are identical to those described previously (Eqs. 1 and 2 in Blasberg et aI., 1983) . In these equations, A is the amount of test substance within the region indicated by the subscript per unit mass of brain tissue; t is time; Cp is plasma concen tration; and K-+;" k2' k3' k4' K*i" and k� are the trans fer rate constants across the membranes separating the plasma and ECF, the ECF and parenchymal cells, and the plasma and r compartment, respec tively. The upper case K's are defined such that K times the concentration of test-substance in the re-gion from which transport occurs is equal to the flux out of the region, they have units of volume per unit mass of tissue per unit time, and, thus, are equiva lent to clearance constants. The lower case k's are defined such that k times the amount of test substance in the region from which transport occurs . is equal to the flux out of the region, and have units of reciprocal time.
We have previously defined Ki to be the usually accepted definition of the transfer (influx) constant (Patlak et aI., 1983) , i.e., the steady-state rate of solute influx across the BBB-complex from plasma (constant concentration) into brain ECF divided by the plasma concentration of the solute. In this model ( Fig. 1 ), Ki is equal to K1, since the BBB is considered to be a single unit-membrane separating plasma from brain ECF. Moreover, the model in cludes the possibility for extravascular tissue com partments in parallel with the BBB that rapidly ex change with plasma (Vr) (Blasberg, et aI., 1983) .
If:
then the solution to Eqs. 1, 2, and 3 is (7) where A br is the total amount of solute in brain parenchyma per unit mass of brain tissue.
The transfer constants for the model in Fig. 1 with AlB were obtained from data presented in the pre vious paper (Blasberg et aI., 1983) in the following manner. The values of K� and k� were calculated from an "empirical" fit of the AlB data for thalamus of the anesthetized rat, which we assume to be typical for the brain (Fig. 3 in Blasberg et aI., 1983) and where K�/k� = Vr; thus, K� = 0.007 1 ml g-I min-I and k1 = 0.25 min-I. K1 was taken to be 0.002 ml g-I min-I (Blasberg et aI., 1983) . It is as sumed that transfer across the capillary membrane is symmetrical, so that k2 = KilVe, where Ve was chosen to be 0. 15 ml g-I to approximate the ex-tracellular space (ECS); hence, k2 = 0.0 13 min-I. To find the values of k 3 and k 4, the cell surface area is assumed to be proportional to the cell volume.
Thus, K3 and K4 per unit area of cell surface would be proportional to k3VeIVc and k4' respectively. Let the prime sign (') denote the parameters in the ex perimental situation described for the mouse brain slices in the Methods section of the previous publi cation (Blasberg et aI., 1983) and assume that the values of K 3 and K 4 per unit area of cell surface for the rat brain are the same as those for the mouse brain slice; then, k3 = k;V�Vc/(VeV�) and k4 = k�.
Thus, using the values discussed before and those in Table 6 of the previous publication (Blasberg et aI., 1983 )-namely, k; = 0.78 min-I, V� = 0.53 ml g-t, V� = 0.27 ml g-t, Ve = 0. 15 ml g-I, Vc = 0.65 ml g-t,
and k� = 0.014 min-I-yields k3 = 6.64 min-I and k4 = 0.0 14 min-I.
The transfer constants for the model in Fig. 1 with DTPA were obtained from the DTPA distribution data in the thalamus of the anesthetized rat (Table 3, and Figs. 4 and 7, respectively, in Blasberg et aI., 1983) . The values are K1 = 0.00002 ml g-I min-I (Blasberg et aI., 1983) , and K1 = 0, since there was no measurable, rapidly reversible, nonvascular tis sue compartment for DTPA; i.e., Vr = 0 (Blasberg et aI., 1983) . Transfer across the capillary mem brane was also assumed to be symmetrical (namely, k2 = KiIVe); Ve was chosen to be 0. 15 ml g-I;
hence, k2 = 0.000 13 min-I. Since DTPA does not enter normal brain cells, k3 is taken to equal zero.
During all modeling, Cp was obtained from the sum of exponentials: 4 Cp(t) = 2: ai exp( -(3it)
where the values of ai and {3i were determined by a least-squares analysis of the 1 4 C-AIB and 57CO DTPA arterial plasma activity data obtained fol lowing intravenous bolus administration of the tracer in six rats over the experimental periods t = 0-240 min and t = 0-270 min, respectively (Blas berg, et aI., 1983) . Cp has been normalized so that it equals 1.0 at t = O. The values that were obtained and used for modeling AlB are al = 0.72, a2 = 0. 14, The amount of test-solute in the vascular com partment of the tissue (Av) parallels the arterial plasma concentration and is given by
where V v is the functional vascular volume per unit mass of brain tissue (Eq. 14 in Blasberg et aI., 1983) . V v for the thalamus of the rat was 0.009 ml g-1 with DTPA and 0.0 12 ml g-1 with AIB (Figs. 7 and 8, respectively, in Blasberg et aI., 1983) .
When determining a blood-to-brain transfer con stant from single-time tissue-uptake data, it is com monly assumed that the BBB-system is a single membrane with an influx constant K l' In addition, it is assumed that backflux or efflux is negligible dur ing the course of the experiment and that there are no rapidly reversible tissue compartments in paral lel or in series with plasma. For such a model, the blood-to-brain transfer constant will be K 1 and may be calculated by (10) Equation 10 is identical to Eq. 5 in the previous publication (Blasberg et aI., 1983) and to the one developed and used by Go and Pratt (1975) , Ohno et al. (1978) , Gjedde and Rasmussen (1980) and Rapoport et aI. (1980) . The transfer constant K 1 is an estimate of the "true" or modeled rate constant Ki, and was calculated from the modeled tissue distribution of the test-substance Abr at time t and the arterial plasma integral j&Cp(r)dr. However, Abr(t) is not measured in the laboratory; what is actually measured is Am(t), the amount of test substance per unit mass of tissue at time t. Thus, Abr(t) is calculated from (11) Therefore, K 1 represents a single-time estimate of Kj (which is equal to Ki for the model presented in Fig. 1 and used in this analysis), and is the value that would be calculated from the data obtained by single-time experiments in the laboratory using the model of the BBB noted at the beginning of this paragraph. Henceforth, K 1 will be described as the "apparent" blood-to-brain transfer constant.
Sequential lO-fold increases in BBB permeability were modeled in the following manner. The basic set of transfer numbers (Ki, k2' ]('It, 0J were se quentially increased, the resultant distribution val ues determined, and apparent blood-to-brain trans fer constants K 1 calculated by Eq. 10. The effect of brain parenchymal cell uptake and/or the brain tis sue distribution volume can also be evaluated by specifying different values for k3 and k 4 and for Ve' 1983 Tissue distribution, K1, and experimental time DTPA. By using Eqs. 4-10 and the values of the parameters listed in the previous section, theoreti cal time-courses of the amounts of DTP A in the brain per unit mass of brain tissue [Abr] and in the vascular compartment per unit mass of brain tissue [Av], plus the apparent single-time blood-to-brain transfer constant [K d were calculated and are pre sented in Fig. 2 . Figure 2a presents the modeled tissue distribution values Abr and Av plus K 1 versus time for DTPA in the brain. Figure 2b -e presents the Abc. Av, and K 1 for DTPA as a function of time for sequential l0-fold increases in BBB "leakiness" over four log orders of magnitude. The time-course of Av is the same for all modeled conditions and reflects the plasma concentration of DTPA (Eq. 9).
According to the modeled conditions, the initial distribution of DTPA is predominantly in the blood or vascular compartment of the tissue, Av > Abr ( Fig. 2a ). After approximately 100 min, Abr > Av. The transfer constant K 1 was essentially constant over 240 min and approximates Ki over this period. This indicates that very little brain-to-blood backflux, relative to the influx, occurred during this period (Fig. 2a ). The calculation of K 1 depends on the amount of DTPA that is in the brain, namely Abc. and the arterial plasma concentration-time integral ISCp(r)dr (Eq. 10). Significant errors could be introduced into the calculation of K 1 if Av is large and not precisely known in relation to Am. Thus, as a "rule of thumb," experiments should be run for a period of time until A m is at least twice the value of Av, in order to accurately determine Abr and K l ' In the case of DTPA, for which the normal blood-to brain transfer constant is approximately 0.00002 ml g-1 min-I, the time should be at least 100 min.
Modeling DTPA distribution for sequential in creases in BBB leakiness by sequential 10-fold in creases in Ki and k2 results in expected changes in Abr and K l ' The initial rise in Abr becomes more rapid and A br reaches a higher maximum value with increasing "leakiness" of the BBB ( Fig. 2a-e ). The magnitude of brain-to-blood backflux also increases with increasing leakiness of the BBB. Significant backflux in Fig. 2 is indicated by a decrease in K 1 as well as in Abr over time. When the transfer constant is 0.0002 ml g-l min-1 (l Ox the normal value), the K I -time relationship has a small negative slope (Fig. 2b ) and the value of K 1 at 240 min is 77% of Ki, When the transfer constant is 0.002 ml g-1 min-1 (100x the normal value for DTPA but similar to the normal value for AlB), the K I -time relationship has a larger negative slope ( Fig. 2c ) and the value of
. " e 100 200 TIME (mini K 1 is one-half of K1 at 77 min and 9.4% of K1 at 240 min. For increasing leakiness of the BBB (l, OOOx and 1O,OOOx the normal transfer constant for DTPA), a similar trend is seen ( Fig. 2d and e, respectively). The initial increase in A br occurs more rapidly and reaches a higher maximum leveL However, brain to-blood backflux soon predominates as plasma levels rapidly decrease and Abr falls. In Fig. 2d and e, Abr closely parallels the plasma arterial concen tration-time relationship, which is indicated by Av (Eq. 9). Rapid flux of DTPA across the BBB results in fairly rapid equilibration between plasma and its tissue distribution volume.
The value of K l under leaky BBB conditions is highly dependent on time. K 1 falls to half of its ini tial value in approximately 9 min for the condition modeled in Fig. 2d and approximately 1 min for the condition modeled in Fig. 2e . These observations clearly indicate that DTPA and similar test molecules cannot be used to accurately estimate blood-to-brain transfer constants of 0.0 1 ml g-l min-l or greater with Eq. 10, unless the experi mental time is very short.
The effect of the tissue distribution volume of DTPA in the tissue on Abr and K b as a function of the experimental time, can be seen from a compari son of Fig. 2e 0.80 ml g-l , respectively. A distribution volume of 0.80 ml g-l represents pathological or "dead" tis sue, the cells of which are freely permeable to DTPA. The leakiness of the BBB in terms of the modeled influx constant was 0.2 ml g-l min-1 in both cases. As expected, Abr rises to a higher value and changes more slowly for the larger distribution volume (Fig. 2f) . Similarly, the initial decrease in K 1 is less rapid in Fig. 2f compared to that in Fig. 2e . Thus, the size of the tissue distribution volume can have a significant effect on the Abr-and K 1-time relationships.
AlB. By using Eqs. 4-10 and the values of the parameters listed in the Modeling section above, time-courses of the amounts of AlB in the tissue on the "brain-side" of the BBB per unit mass of brain tissue [Ae + Ac], in the rapidly equilibrating tissue region on the "blood-side" of the BBB per unit mass of brain tissue [Ar] , and in the vascular com partment per unit mass of brain tissue [Av], plus the apparent blood-to-brain transfer constant [K 1] were calculated; they are presented in Fig. 3 . The tissue distribution values ([Ae + Ac], An and Av) and K 1 were generated as uescribed above for the model of blood-brain transport in Fig. 1 . However, [Ae + Ac] and Ar cannot be determined separately from the experimental data obtained from single-time ex periments with AlB, since Abr is given by Eq. 11 and includes Ar as well as [Ae + Ac] (Eq. 7). There-10° a 10' /' AlB listed in the text. The control or normal condition for AlB blood-to-brain transport in the thalamus of the anesthetized rat (K; = 0.002 ml g-' min-'; Blasberg et aI., 1983) is modeled in (a). Serial 10-fold increases BBB transport are modeled in (b) and (c), such that Kt k2' K;, and k; increase propor tionately, and Ve and V, remain constant [(b) K; = 0.02, and (c and d) K; = 0.2 ml g-' min-']. The values for the other rate constants of the model (Fig. 1) were obtained as described in the text (see Modeling Blood-Brain Transfer). In (d), the an atomical distribution volume of AlB was assumed to equal 0.80 ml g-' and k3 to equal zero, fore, K 1, which was calculated by Eq. 10, will be an overestimation of K-; in the absence of backflux with AlB. The modeled tissue distribution values ([Ae + Ac], An and Av) and K 1 versus time after bolus intrave nous administration of AlB are presented graphi cally in Fig. 3a . Figure 3b and c present the tissue distribution values and K 1 as a function of time for two sequential lO-fold increases in BBB leakiness that were modeled by sequential lO-fold increases in K-;, k2' K>IJ., and k�. The time course of Av is the same for all modeled conditions and reflects the blood concentration of AlB (Eq. 9).
The initial distribution of AlB is predominantly in the blood or vascular compartment of the tissue and J Cereb Blood Flow Metabol, Vol. 3, No. 2, 1983 in the rapidly equilibrating tissue region, [Av + Ar] > [Ae + Ac] (Fig. 3a) . Brain parenchymal activity, [Ae + Ac], continues to increase over 240 min, whereas Ar falls after its initial rise and parallels Av. By 10 min, [Ae + Ac] > Ar, and by 20 min, [Ae + Ac] > [Av + Ar]. Brain ti s sue activity Abr increases more rapidly with AlB than with DTPA ( Figs. 2a  and 3a , respectively); this would be expected from the differences in the blood-to-br a in transfer con stants of these two test-molecules (Blasberg et aI., 1983) . Under conditions in which the BBB is leaky to DTPA such that the transfer constant of DTPA equals that of AlB (Figs. 2c and 3a) , Abr initially increases more rapidly with AlB than with DTPA. This is due to the rapid uptake of AlB (but not DTPA) into a reversible tissue compartment, Yr' The comparatively high value of Ar during this period with AlB is reflected by the time course of K 1 (Fig. 3a) , which is considerably higher than K-; during the early experimental peri ods. A similar K 1-time relationship was observed experimentally (Fig. 13 in Blasberg et aI., 1983) . The apparent transfer constant K 1 decreases rapidly from its initial value and then reaches a plateau; by 9 min, it is roughly twice K"'i, and by 30 and 240 min, it is 1.29 and 1.03 times the modeled value of the influx constant, respectively (Fig. 3a) .
Modeling AlB distribution for sequential in creases in BBB leakiness also results in expected changes in An [Ae + Ac], and K l' The initial increase in A r and [A e + A c] is more rapid and A br continues to increase over 240 min with increasing leakiness of the BBB (Fig. 3a-c) . After the initial decline in K 1J the K 1-time relationship is essentially linear and has a small, negative slope. Modeling K-; = 0.02 ml g-1 min-1 (Fig. 3b ) results in K /K-; ratios of 1.06, 1.00, and 0.94 at 10, 30, and 240 min, respectively. In Fig. 3c , where K-; = 0.2 ml g-1 min-I , K 1 is 0.83 times K-; at 10 min; by 30 min, K 1 is 0.80 times the modeled value of the influx constant, and by 240 min, the fractional relationship is 0.59.
Extracellular fluid distribution. The distribution
of AlB and DTPA in the ECF of the brain is given by Eq. 1. Although the amount or concentration of AlB in the ECF cannot be measured experimen tally, it can be obtained in the modeling exercise and compared to that of DTPA. The concentration of test-solute in the ECF is obtained by AelVe, where Ve is the anatomical volume of the ECF per unit mass of brain tissue and is equivalent to the ECS (0. 15 ml g-1 ). A direct comparison between ECF and plasma concentrations is given by C e/C p' The relationships between the ECF/plasma con centration ratio (Ce/Cp) of DTPA, the experimental time, and increasing leakiness of the BBB are pre-sented graphically in Fig. 4a and are directly com parable to the same relationships with AIB ( Fig.   4b ). In this figure, the C.)Cp ratio reflects the con centration gradient for blood -brain exchange. The ECF distribution of AIB increases slowly with time and is proportionately greater for in creases in the transfer constants modeled in Fig. 4b . The effect of parenchymal cell uptake on the ECF distribution of AlB is clearly seen by a comparison to the brain (ECF) distribution of DTPA (Fig. 4a ). Under normal conditions in the anesthetized rat, in which the blood-to-brain transfer constant of AlB is approximately 100-fold greater than that of DTPA (Blasberg et aI., 1983) , the C.)Cp ratio of AIB is less than that of DTPA beyond 7 min. For similar rates of blood-to-brain transfer, the ECF/plasma dis tribution ratio of AlB is always less than that with DTPA. Under these conditions, brain-to-blood backflux will always be less with AIB, compared to that with DTPA.
For example, when the modeled influx constant is approximately 0.002 ml g-I min-I, the DTPA in the ECF equilibrates with that in plasma by 40 min (Fig.  4a ). Subsequently, ECF concentrations of DTPA exceed those in plasma because plasma concentra tions decrease more rapidly than that in the ECF. This is due to the rapid plasma clearance of DTP A relative to its brain-to-blood backflux. For increas ing rates of influx (0.02 and 0.2 ml g-I min-I), the time for DTP A equilibration between plasma and ECF decreases to approximately 6 and 0.6 min, re spectively. In the case of AlB and normal brain capillaries, when the blood-to-brain transfer con stant is approximately 0.002 ml g-I min-I (Blasberg et aI., 1983) , nearly 3 h are required for the ECFI plasma concentration ratio to reach 11 100. For blood-to-brain transfer rates of 0.02 and 0.2 ml g-I min-I, and normal parenchymal cell uptake of AlB, the equivalent ECF/plasma concentration ratios at 30 min are 1127 and 114, respectively.
The differences between AIB and DTP A demon strated in Fig. 4 are primarily due to the rapid parenchymal cell uptake and trapping of the amino acid and the essential impenetrability of normal cell membranes to DTPA. This results in a lower Ce/Cp ratio and gradient for brain-to-blood backflux with AIB in comparis(m to DTPA. Under actual experi mental conditions that result in a very leaky BBB, it is unlikely that cell transport mechanisms will re main normal. Thus, the actual ECF distribution of AlB in pathological conditions is likely to be some what higher than those modeled in Fig. 4b .
Cellular distribution. The distribution of a test
substance in the cells of the brain is given by Eq. 2. In the case of AlB, most of its distribution in brain tissue was shown to be within the cellular compart ment due to its rapid cell uptake (Blasberg et aI., 1983) . The differences in the A hr versus time and the K I versus time relationships between the conditions modeled in Fig. 3a -c with AIB and those in Fig.  2c -e with DTPA are primarily due to parenchymal cell uptake and "trapping" of AlB once it has crossed the BBB. It should be recalled that the same values of Ki were modeled in Figs. 2c and 3a (0.002 ml g-l min-I), 2d and 3b (0.02 ml g-l min-I), and 2e, 2f, 3c, and 3d (0.2 ml g-l min-I). The differences in blood -brain exchange due to cellular uptake are demonstrated by a comparison of Fig. 3c and d as well as Figs. 3d and 2f . Transport across paren chymal cell membranes and concentrative cell up take was modeled to be normal in Fig. 3c , but nonexistent for the condition modeled in Fig. 3d . Thus, Figs. 3d and 2f represent the state of patho logical or "dead" tissue in which the cells are freely FIG. 4 . Time-course of the brain ECF to plasma concentration ratio, CJCp, for different rates of transfer across the BBB with DTPA (a) and AlB (b). The modeled transfer rates across the BBB in (a) were 0.00002 ml g-1 min-1 (-. . -) (normal value with DTPA in the thalamus of the anesthetized rat; Blasberg et aI., 1983) ; 0.0002 ml g-1 min-1 (-. -); 0.002 ml g-1 min-1 (-); 0.02 ml g-1 min-1 (----); and 0.2 ml g-1 min-1 (--). The modeled transfer rates across the BBB in (b) were 0.002 ml g-1 min-1 (-) (normal value with AlB in the thalamus of the anesthetized rat; Blasberg et aI., 1983) ; 0.02 ml g-1 min-1 (----); and 0.2 ml g-1 min-1 (--). The ECS was assumed to be 0.15 ml g-1 min-1 and the physiological distribution volume in the ex tracellular compartment of the tissue is equal to Ae(t)/Cp(t); for DTPA, Ae = Ab,. The vascular distribution volume of DTPA and AlB in the thalamus of the anesthetized rat was 0.009 and 0.012 ml g-1, respectively (Blasberg et aI., 1983) . permeable to both AlB and DTPA, respectively (the tissue distribution volume was chosen to be 0.80 ml g-I and k3 = 0 in both figures).
Modeling concentrative parenchymal cell uptake of AlB results in higher values of A br and only a relatively small decline in K l over time (Fig. 3c ) compared to the values obtained by modeling no concentrative cell uptake (Fig. 3d ). In the absence of concentrative parenchymal cell uptake, the dis tribution in brain and K 1 with AlB is similar to that with DTPA over the first 20-40 min (Figs. 3d and  2f , respectively). The major differences in Abr and K 1 with AlB and DTPA under these conditions during the latter portion of the 240-min time-course are due to the more rapid clearance of DTP A from plasma, compared to that of the amino acid (Figs. 3d and 2f, respectively). For the same distribution volume(s) and transfer constants across the BBB, the greater the rate of plasma clearance is, the greater the net brain-to-blood backflux and the lower the calculated value of K 1 will be. Thus, the rate of plasma clearance as well as the equilibrium dis tribution volume of the test-molecule in the tissue can alter the A brand K 1 -time relationships for a given or modeled blood-to-brain transfer constant.
Comparison of K I determinations with AlB and DTPA
A comparison of K 1 calculated from the modeled distribution values of AlB and DTPA for compara-
ble rates of transfer across the BBB can be obtained from a review of Figs. 3a-c and 2c-e, respectively. The modeled influx constants were 0.002, 0.02, and 0.2 ml g-I min-I in these figures. It is clear from this comparison that the value of K 1 calculated from the modeled tissue distribution of AlB is less influenced by the length of the experimental period than is the value of K I obtained with DTPA, particularly at the higher rates of transfer. The length of the experi ment is a variable that can be specified to optimize the measurement of Am and Av and to minimize brain-to-blood backflux. Thus, time is an important experimental parameter with respect to obtaining an accurate estimate of the blood-to-brain transfer constant from experimental data obtained with single-time studies and Eq. 10. The relationship of time to the accuracy of K I > determined by single-time experiments and Eq. 10, can also be seen by comparing Fig. 5a-d . A range of influx constants across the BBB (Kt) were mod eled and the corresponding estimates of these con stants (K I ) were obtained from the modeled tissue and plasma distribution values for both DTPA and AlB, as described above. Curves representing the graphical relationship between K 1 and K� at four different experimental times (3, 10, 30, and 90 min) are presented in Fig. 5a-d for both test-substances. The identity of K 1 and K� in Fig. 5a-d is indicated by the fine solid line, which has a slope of 1.
The heavy dashed portions of each curve for AlB and DTPA represent the range of "reliable" Ki es timates that can be obtained for the modeled condi tions with Eqs. 9 and 10, namely K b and the ex perimental time specified for each graph. The dot ted portion of the curve toward the right of each graph represents the range of high transfer con stants where K 1 is less than half of Ki. The lower value of K 1 in this region is due to significant brain-to-blood backflux during the specified ex perimental time. The dotted portion of the curves toward the left of each graph represent a range of low Ki values for which the amount of test-material in the brain Abr is less than twice the amount in the vascular compartment Av. In this region of the curve, small errors in measurement of Am or Av will produce large errors in the value of A br (Eq. 9) and, thus, in K 1 (Eq. 10).
In the case of AlB and low transfer rates across the BBB, the value of K 1 is greater than that of Ki and, therefore, above the solid line of K 1-Ki equality (Fig. 5) . The difference is particularly prominent during the initial period following in travascular administration (short experimental times) and is due to the more rapid uptake of AlB into a reversible tissue compartment, An than to its transfer across the BBB, [Ae + Ac]. A comparable segment of the DTP A curve above the solid line of K 1-Ki equality is not seen since there is no transfer of this test-solute into the reversible compart ment Vr• For short experimental times, the reliable range of the AlB and DTPA curves are fairly close to each other, as well as to the solid line representing K 1-Ki equality. The range of modeled transfer rates across the BBB (K+J in which reliable K 1 val ues can be obtained with DTPA and 3-min experi ments extends from 0.004 to 0.06 ml g-l min-1 (Fig.   5a ). In the case of AlB and 3-min experiments, reli able K 1 values can be obtained for transfer rates between 0.008 and approximately 1 ml g-l min-1 (Fig. 5a) , provided the parenchymal cell transport of AlB is unaltered (i.e., k3 and k4 remain un changed), and is described by Eq. 2. For longer experimental times, the reliable range of the AlB and DTPA curves separate; the greatest change is seen with DTPA, as the dashed portion of the curve shifts to a lower K 1-Ki range ( Fig.  5a-d) . Reliable K 1 values with DTPA and 90-min experiments are obtained from modeled transfer rates between 0.00006 and 0.002 ml g-l min-1 (Fig.  5d ). With AlB and 90-min experiments, reliable K 1 values can be obtained for transfer rates between 0.002 (control values) and 0.6 ml g-l min-1 (Fig. 5d) , provided the parenchymal cell transport of AlB is unaltered. Under pathological conditions in which k3 and k4 are likely to be altered, the actual or ex perimental curves with AlB in Fig. 5a-d are likely to lie somewhere between that modeled for AlB and that for DTPA, respectively. This would result from less effective "cellular trapping, " comparatively higher E CF concentrations, and greater brain-to blood backflux during the experimental period.
DISCUSSION
This exercise in modeling transport across the BBB illustrates various problems associated with estimating Ki by single-time experiments. By defi nition, Ki is the steady-state rate of unidirectional solute flux from a constant plasma concentration across the BBB into the brain divided by the plasma concentration. In a previous paper, we showed that Ki can be determined from experimental data ob tained under conditions of changing plasma con centrations (Patlak et aI., 1983) . Estimates of Ki are important for any investigation of blood-brain ex change or functional integrity of the BBB. First, with knowledge of Kb blood flow, and the distribu tion of the test-solute in the blood, it is possible to calculate an extraction fraction of that solute and the permeability-surface area product of the BBB with respect to the test-substance (Fenstermacher et aI., 198 1; Blasberg et aI., 1983) . Second, it is possible to characterize the functional properties of the BBB by comparing different test-solutes. Third, changes in the characteristics of the BBB induced by various pathological states can be studied in a quantitative manner (Blasberg et aI., 1980, 198 1) .
Accurate estimates of unidirectional blood-to tissue transfer constants from single-time experi ments and the transport model used by Go and Pratt (1975) , Ohno et ai. (1978) , and Gjedde and Rasmus sen (1980) can be obtained, provided (1) tissue-to blood backflux is insignificant during the experi mental period, (2) the distribution of the test-sub stance in the blood vessels and in the extravascular tissue compartment(s) that rapidly exchange with the blood (Vr) is negligible or accurately known, and (3) the experimental time is sufficiently long to permit an accurate determination of the amount of test-solute that has actually crossed the BBB. An estimate of unidirectional flux across blood vessels can also be obtained from single-time experiments during which significant bidirectional flux occurs, provided a more complex transport model is assumed and the data are processed by compartmental analysis. However, compartmental analysis of single-time experiments requires addi tional knowledge, such as the equilibrium volume(s) of distribution and the arterial plasma concentra-tion-time-course of the test-molecule rather than just the plasma arterial integral (Eq. 10). For example, the Kety (1959 Kety ( , 1960 tissue-uptake method for determining blood flow assumes a sim ple two-compartment model (blood and tissu�) and bidirectional flux between these compartments, and requires knowledge of the equilibrium tissue-to blood concentration ratio (,\) as well as the arterial blood concentration -time-course of the test substance. A similar compartmental model was used by Ohno et al. (1978) to determine unidirectional blood-to-brain transfer rates. However, the results from any compartmental analysis of experimental data are highly specific for the particular com partmental model chosen. Levin and Patlak (1972) demonstrated this limitation by obtaining two dif ferent sets of transfer numbers from an analysis of their data by two different compartmental models.
The influence of the form of the arterial plasma concentration -time relationship on the determina tion of K I by single-time experiments and Eq. 10 was briefly mentioned above and has been dis cussed previously ). We con cluded that bolus intravenous administration of the test-solute yields the optimal plasma concentra tion-time relationship for single-time experiments, since the Cp(t)lfbCp(T)dT ratio is minimized by bolus administration of the test-substance. Rapid plasma clearance of the test-substance reduces the Cp(t)1 f6Cp(T)dT ratio and effectively results in a "length ening" of the experimental time, compared to experi ments in which plasma levels are constant. Namely, the reciprocal of the above relationship UlCp(T)dTI C p(t)] has the units of time and is the abscissa for the graphical method of analysis of multiple-time tissue-uptake data . In the case of AlB, this ratio was approximately 400 min for 240-min experiments ( Fig. 3a in Blasberg et al., 1983) ; for DTPA it was between 5,000 and 14,000 min for 270-min experiments (Fig. 4a in .
The choice of an appropriate experimental time is essential for an accurate estimate of Ki from single-time studies and Eq. 10, since tissue and vas cular distribution of the test-substance must be ac curately measured and tissue-to-blood backflux during the experimental period must be minimized. The appropriate experimental tiltle will vary and depends on the range of transfer rates to be mea sured, the arterial plasma concentration-time course and tissue distribution space of the test substance. For moderate to large transfer rates across the BBB, compounds such as AlB and N-methyl-AlB (MeAIB) have a distinct advantage over other J Cereh Blood Flow Metahol, Vol. 3, No. 2. 1983 test-molecules, such as DTPA and sucrose, for ac curately estimating the transfer rate from single time experiments and Eq. 10. The advantage of AlB and MeAIB is due to the relatively slow transport of these amino acids across normal brain capillaries and their rapid uptake by normal brain cells. These characteristics are also shared by potassium (Brad bury and Davson, 1965; Cserr, 1965) and rubidium (Love et al., 1954; Yen et al., 1982) . These com pounds and ions are optimally used to measure moderate to large values of the transfer rate(s) across the BBB.
The sensitivity of a test-molecule to measure smail, nonspecific changes in transfer across the BBB (e.g., the opening of channels) is established by the transfer rate constant of the test-molecule across normal brain capillaries. The Ki of normal brain capillaries with DTPA is roughly 11 100 that with AlB. Thus, DTPA, as a test-solute, is consid erably more sensitive to small changes in the trans fer rate across the BBB than is either AlB or MeAIB. DTPA and other compounds, such as su crose, EDT A, and proteins, can be used to accu rately measure small to moderate increases in the blood-to-brain transfer constant by single-time ex periments, provided an appropriate experimental time is chosen. The measurement of small changes in the BBB can only be accomplished with test molecules having an appropriate sensitivity range, namely, test-substances with low rates of transfer across normal brain capillaries.
CONCLUSIONS
Accurate estimates of blood-to-brain transfer rate constants can be obtained from single-time experi ments and Eq. 10, provided the amount of test substance crossing the BBB during the experimen tal period and the plasma arterial concentra tion-time integral can be reliably determined. AlB and MeAIB have an advantage over other test molecules such as DTPA for estimating moderate (approximately 0.0 1 ml g-I min-I) to large (0. 1-1.0 ml g-I min-I) values of the blood-to-brain transfer rate constant; this is due to their rapid parenchymal cell uptake, comparatively low ECF concentra tions, and low rates of brain-to-blood backflux. On the other hand, DTPA has greater sensitivity and can be used to estimate small (0.000 1-0.00 1 ml g-I min-I) values of the blood-to-brain transfer rate constant. The experimental time is critical for ob taining accurate experimental estimates of Ki from single-time experiments and it will be different for different arterial plasma concentration -time courses as well as different ranges of Ki. Thus, the investigator can choose a particular test-substance for a particular range of transfer rate constants across the BBB and can optimize the measurement and estimate of Ki by using bolus intravenous ad ministration of the test-solute and by specifying the appropriate experimental time.
